FY2027 Earnings Forecast for Denali Therapeutics Inc. (NASDAQ:DNLI) Issued By HC Wainwright

Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Equities research analysts at HC Wainwright upped their FY2027 EPS estimates for shares of Denali Therapeutics in a research report issued on Wednesday, May 8th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of $1.99 per share for the year, up from […]

Leave a Reply

Your email address will not be published.

Previous post DA Davidson Increases Lyft (NASDAQ:LYFT) Price Target to $18.00
Next post AutoZone, Inc. (NYSE:AZO) Shares Sold by Spire Wealth Management